These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 21988318
21. Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system. Filippi L, Dal Monte M, Casini G, Daniotti M, Sereni F, Bagnoli P. Med Res Rev; 2015 May; 35(3):619-52. PubMed ID: 25523517 [Abstract] [Full Text] [Related]
22. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha. Xia XB, Xiong SQ, Xu HZ, Jiang J, Li Y. Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324 [Abstract] [Full Text] [Related]
23. Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity. Rabinowitz R, Priel A, Rosner M, Pri-Chen S, Spierer A. Curr Eye Res; 2012 Jul; 37(7):624-9. PubMed ID: 22578253 [Abstract] [Full Text] [Related]
24. Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1. Joe SG, Yoon YH, Choi JA, Koh JY. PLoS One; 2015 Jul; 10(3):e0119708. PubMed ID: 25785990 [Abstract] [Full Text] [Related]
25. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy. Lee YM, Lee YR, Kim CS, Jo K, Sohn E, Kim JS, Kim J. Int J Mol Sci; 2015 Dec 16; 16(12):29900-10. PubMed ID: 26694358 [Abstract] [Full Text] [Related]
26. Astragalus root extract inhibits retinal cell apoptosis and repairs damaged retinal neovascularization in retinopathy of prematurity. Liu X, Wang B, Sun Y, Jia Y, Xu Z. Cell Cycle; 2019 Nov 16; 18(22):3147-3159. PubMed ID: 31564208 [Abstract] [Full Text] [Related]
27. Retinal vascular development and oxygen-induced retinopathy: a role for adenosine. Lutty GA, McLeod DS. Prog Retin Eye Res; 2003 Jan 16; 22(1):95-111. PubMed ID: 12597925 [Abstract] [Full Text] [Related]
28. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy. Ehlken C, Martin G, Lange C, Gogaki EG, Fiedler U, Schaffner F, Hansen LL, Augustin HG, Agostini HT. Acta Ophthalmol; 2011 Feb 16; 89(1):82-90. PubMed ID: 19764912 [Abstract] [Full Text] [Related]
29. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat. van Wijngaarden P, Brereton HM, Gibbins IL, Coster DJ, Williams KA. Exp Eye Res; 2007 Oct 16; 85(4):508-17. PubMed ID: 17692314 [Abstract] [Full Text] [Related]
30. Retinal proteome analysis in a mouse model of oxygen-induced retinopathy. Kim SJ, Jin J, Kim YJ, Kim Y, Yu HG. J Proteome Res; 2012 Nov 02; 11(11):5186-203. PubMed ID: 23039900 [Abstract] [Full Text] [Related]
31. CEACAM1 confers resistance toward oxygen-induced vessel damage in a mouse model of retinopathy of prematurity. Ludewig P, Flachsbarth K, Wegscheid C, Tiegs G, Richard G, Wagener C, Bartsch U, Horst AK. Invest Ophthalmol Vis Sci; 2014 Nov 18; 55(12):7950-60. PubMed ID: 25406283 [Abstract] [Full Text] [Related]
32. Propranolol increases vascular permeability through pericyte apoptosis and exacerbates oxygen-induced retinopathy. Yun JH, Koh YJ, Jeong HS, Lee DH, Lee EH, Cho CH. Biochem Biophys Res Commun; 2018 Sep 18; 503(4):2792-2799. PubMed ID: 30100069 [Abstract] [Full Text] [Related]
33. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy. Zhao M, Shi X, Liang J, Miao Y, Xie W, Zhang Y, Li X. Exp Eye Res; 2011 Dec 18; 93(6):921-6. PubMed ID: 22067127 [Abstract] [Full Text] [Related]
34. M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy. Zhou Y, Yoshida S, Nakao S, Yoshimura T, Kobayashi Y, Nakama T, Kubo Y, Miyawaki K, Yamaguchi M, Ishikawa K, Oshima Y, Akashi K, Ishibashi T. Invest Ophthalmol Vis Sci; 2015 Jul 18; 56(8):4767-77. PubMed ID: 26218904 [Abstract] [Full Text] [Related]
35. Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy. Vessey KA, Wilkinson-Berka JL, Fletcher EL. J Comp Neurol; 2011 Feb 15; 519(3):506-27. PubMed ID: 21192081 [Abstract] [Full Text] [Related]
36. Ghrelin modulates physiologic and pathologic retinal angiogenesis through GHSR-1a. Zaniolo K, Sapieha P, Shao Z, Stahl A, Zhu T, Tremblay S, Picard E, Madaan A, Blais M, Lachapelle P, Mancini J, Hardy P, Smith LE, Ong H, Chemtob S. Invest Ophthalmol Vis Sci; 2011 Jul 23; 52(8):5376-86. PubMed ID: 21642627 [Abstract] [Full Text] [Related]
37. Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy. Werdich XQ, McCollum GW, Rajaratnam VS, Penn JS. Exp Eye Res; 2004 Nov 23; 79(5):623-30. PubMed ID: 15500821 [Abstract] [Full Text] [Related]
38. Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression. Nakamura S, Tsuruma K, Shimazawa M, Hara H. Eur J Pharmacol; 2012 Jun 15; 685(1-3):8-14. PubMed ID: 22543084 [Abstract] [Full Text] [Related]
39. Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR. Barnett JM, McCollum GW, Fowler JA, Duan JJ, Kay JD, Liu RQ, Bingaman DP, Penn JS. Invest Ophthalmol Vis Sci; 2007 Feb 15; 48(2):907-15. PubMed ID: 17251494 [Abstract] [Full Text] [Related]
40. Role of cytosolic phospholipase A(2) in retinal neovascularization. Barnett JM, McCollum GW, Penn JS. Invest Ophthalmol Vis Sci; 2010 Feb 15; 51(2):1136-42. PubMed ID: 19661235 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]